Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21.
Lancet. 2016.
PMID: 26719232
Free PMC article.
Clinical Trial.
Use of systemic therapy in the treatment of choroidal metastases from breast cancer.
Alzouebi M, Ramakrishnan S, Rennie I, Salvi S.
Alzouebi M, et al.
BMJ Case Rep. 2014 Nov 26;2014:bcr2013009088. doi: 10.1136/bcr-2013-009088.
BMJ Case Rep. 2014.
PMID: 25427924
Free PMC article.
Item in Clipboard
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O'Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell JM, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ.
Woods BS, et al. Among authors: alzouebi m.
Eur Urol Oncol. 2018 Dec;1(6):449-458. doi: 10.1016/j.euo.2018.06.004. Epub 2018 Sep 14.
Eur Urol Oncol. 2018.
PMID: 31158087
Free PMC article.
Clinical Trial.
Item in Clipboard
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Attard G, Murphy L, Clarke NW, Sachdeva A, Jones C, Hoyle A, Cross W, Jones RJ, Parker CC, Gillessen S, Cook A, Brawley C, Gilson C, Rush H, Abdel-Aty H, Amos CL, Murphy C, Chowdhury S, Malik Z, Russell JM, Parkar N, Pugh C, Diaz-Montana C, Pezaro C, Grant W, Saxby H, Pedley I, O'Sullivan JM, Birtle A, Gale J, Srihari N, Thomas C, Tanguay J, Wagstaff J, Das P, Gray E, Alzouebi M, Parikh O, Robinson A, Montazeri AH, Wylie J, Zarkar A, Cathomas R, Brown MD, Jain Y, Dearnaley DP, Mason MD, Gilbert D, Langley RE, Millman R, Matheson D, Sydes MR, Brown LC, Parmar MKB, James ND; STAMPEDE investigators.
Attard G, et al. Among authors: alzouebi m.
Lancet Oncol. 2023 May;24(5):443-456. doi: 10.1016/S1470-2045(23)00148-1.
Lancet Oncol. 2023.
PMID: 37142371
Free article.
Item in Clipboard
Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre.
Alzouebi M, Goepel JR, Horsman JM, Hancock BW.
Alzouebi M, et al.
Int J Oncol. 2012 Jun;40(6):2075-80. doi: 10.3892/ijo.2012.1387. Epub 2012 Feb 22.
Int J Oncol. 2012.
PMID: 22367111
Item in Clipboard
Acute polyradiculoneuropathy with renal failure: mind the anion gap.
Alzouebi M, Sarrigiannis PG, Hadjivassiliou M.
Alzouebi M, et al.
J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):842-4. doi: 10.1136/jnnp.2008.144915.
J Neurol Neurosurg Psychiatry. 2008.
PMID: 18559464
Item in Clipboard
Cite
Cite